|
Title: Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than ... Post by: Ljsmalls on Jan 24, 2018 Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than an infusion of mycophenolate (CellCept)?
a. Muromonab-CD3 is administered for shorter time periods than is mycophenolate. b. Muromonab-CD3 is administered in much higher dosages than is mycophenolate. c. Mycophenolate is an antiproliferative agent and muromonab-CD3 is a polyclonal antibody. d. Mycophenolate is a synthetically manufactured drug and muromonab-CD3 is produced using mouse proteins. Title: Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than ... Post by: ljko on Jan 24, 2018 Content hidden
|